natgillin/translations-raw huggingface dataset:
Where the screener cannot determine whether or not the cargo or mail contains any prohibited articles, it shall be rejected or rescreened to the screener’s satisfaction.
Kadar pregledovalec ne more ugotoviti, ali tovor oziroma pošta vsebuje morebitne prepovedane predmete ali ne, se prtljaga zavrne ali znova pregleda, dokler pregledovalec ni zadovoljen z izidom.
The following means or method may be applied only where it is not possible to apply any of the other means or methods specified in point 6.2.1.5 owing to the nature of the consignment:
Naslednji način ali metoda se lahko uporabi le, če zaradi narave pošiljke ni mogoče uporabiti nobenega drugega načina ali metode iz točke 6.2.1.5:
other appropriate security controls, if agreed by the appropriate authority and notified to the Commission.’
drugi ustrezni varnostni nadzor, če je tako dogovorjeno z ustreznim organom in je Komisija o tem obveščena.“
Chapter 8 is amended as follows:
Poglavje 8 se spremeni:
The following point 8.1.2.3 is added:
doda se naslednja točka 8.1.2.3:
The following means or method of screening, either individually or in combination, shall be applied:
Uporabijo se naslednji načini ali metode pregledovanja, posamično ali v kombinaciji:
ETD equipment in combination with point (a);
z napravami ETD v kombinaciji s točko (a);
explosive detection dogs in combination with point (a).
s psi za odkrivanje eksplozivov v kombinaciji s točko (a).
Where the screener cannot determine whether or not the item contains any prohibited articles, it shall be rejected or rescreened to the screener’s satisfaction.’
Kadar pregledovalec ne more ugotoviti, ali predmet vsebuje morebitne prepovedane predmete ali ne, se prtljaga zavrne ali znova pregleda, dokler pregledovalec ni zadovoljen z izidom.“
The following point 9.1.2.3 is added:
doda se naslednja točka 9.1.2.3:
The following point 12.0.3 is added:
doda se naslednja točka 12.0.3:
Equipment manufacturers shall provide a concept of operations and equipment shall be used in accordance with it.’
Proizvajalci naprav predložijo koncept ravnanj, oprema pa se uporablja v skladu z njim.“;
Point 12.6 is replaced by the following:
točka 12.6 se nadomesti z naslednjim:
EXPLOSIVE TRACE DETECTION (ETD) EQUIPMENT
NAPRAVE ZA ZAZNAVANJE SLEDI EKSPLOZIVOV (ETD)
ETD equipment shall be able to collect and analyse trace levels of particles or vapour from contaminated surfaces, or the contents of baggage or consignments, and indicate, by means of an alarm, the presence of explosives.
Naprave ETD lahko zbirajo in analizirajo sledi delcev ali pare s kontaminiranih površin ali vsebine prtljage ali pošiljk ter z alarmom opozorijo na prisotnost eksplozivov.
For the purpose of screening, it shall meet the following requirements:
Za namene pregledovanja morajo izpolnjevati naslednje zahteve:
Consumables shall not be used beyond the recommendations of the manufacturer of the consumable or if the performance of the consumable appears to have deteriorated through use
Potrošni material se ne sme uporabljati drugače kot po priporočilih proizvajalca potrošnega materiala ali če je videti, da se je delovanje potrošnega materiala z uporabo poslabšalo.
ETD equipment shall only be used in an environment for which the equipment has been approved for use
Naprave ETD se lahko uporabljajo samo v okolju, za katerega so bile odobrene za uporabo.
There shall be standards for ETD set for particulate and vapour sampling.
Vzpostavijo se standardi za ETD za vzorčenje delcev in pare.
Detailed requirements on these standards are laid down in a separate classified Commission Decision.’
Podrobne zahteve glede teh standardov so predpisane v ločenem tajnem sklepu Komisije.“;
The following points 12.6.2 and 12.6.3 are added:
dodata se naslednji točki 12.6.2 in 12.6.3:
The standard for ETD equipment that uses particulate sampling shall apply to ETD equipment deployed from 1 September 2014.
Standard za naprave ETD, ki uporabljajo vzorčenje delcev, se uporablja za naprave ETD, ki se uporabljajo od 1. septembra 2014.
The appropriate authority may permit ETD equipment not certified to comply with attachment 12-L that was deployed before 1 July 2014 and uses particulate sampling to continue to be used until 1 July 2020 at the latest.’
Pristojni organ lahko dovoli nadaljnjo uporabo naprav ETD, za katere ni bilo izdano potrdilo o skladnosti z dodatkom 12-L ter ki so se uporabljale pred 1. julijem 2014 in uporabljajo vzorčenje delcev, in sicer najpozneje do 1. julija 2020.“
Commission Implementing Regulation (EU) No 279/2014
Izvedbena uredba Komisije (EU) št. 279/2014
Commission Implementing Regulation (EU) No 280/2014
Izvedbena uredba Komisije (EU) št. 280/2014
on the issue of import licences for applications lodged during the first seven days of March 2014 under the tariff quotas opened by Regulation (EC) No 533/2007 for poultrymeat
o izdaji uvoznih dovoljenj na podlagi zahtevkov, predloženih v prvih sedmih dneh meseca marca 2014 v okviru tarifnih kvot za perutninsko meso, odprtih z Uredbo (ES) št. 533/2007
Having regard to Regulation (EU) No 1308/2013 of the European Parliament and of the Council of 17 December 2013 establishing a common organisation of the markets in agricultural products and repealing Council Regulations (EEC) No 922/72, (EEC) No 234/79, (EC) No 1037/2001 and (EC) No 1234/2007 [1] and in particular Article 188 thereof,
ob upoštevanju Uredbe (EU) št. 1308/2013 Evropskega parlamenta in Sveta z dne 17. decembra 2013 o vzpostavitvi skupne ureditve trgov kmetijskih proizvodov in razveljavitvi uredb Sveta (EGS) št. 922/72, (EGS) št. 234/79, (ES) št. 1037/2001 in (ES) št. 1234/2007 [1],
The applications for import licences lodged during the first seven days of March 2014 for the subperiod from 1 April to 30 June 2014 relate, for some quotas, to quantities exceeding those available.
Količine v zahtevkih za uvozna dovoljenja, predloženih v prvih sedmih dneh meseca marca 2014 za podobdobje od 1. aprila do 30. junija 2014, so pri nekaterih kvotah višje od razpoložljivih.
The quantities for which import licence applications have been lodged under Regulation (EC) No 533/2007 for the subperiod from 1 April to 30 June 2014 shall be multiplied by the allocation coefficients set out in the Annex to this Regulation.
Za zahtevke za uvozna dovoljenja, ki so v skladu z Uredbo (ES) št. 533/2007 predloženi za podobdobje od 1. aprila do 30. junija 2014 se uporabijo koeficienti dodelitve iz Priloge k tej uredbi.
This Regulation shall enter into force on 20 March 2014.
Ta uredba začne veljati 20. marca 2014.
Allocation coefficient for import licence applications lodged for the subperiod from 1.4.2014-30.6.2014
Koeficient dodelitve za zahtevke za uvozna dovoljenja, predložene za podobdobje od 1.4.2014–30.6.2014
Commission Implementing Regulation (EU) No 281/2014
Izvedbena uredba Komisije (EU) št. 281/2014
on the issue of import licences for applications lodged during the first seven days of March 2014 under the tariff quota opened by Regulation (EC) No 1385/2007 for poultrymeat
o izdaji uvoznih dovoljenj na podlagi zahtevkov, predloženih v prvih sedmih dneh meseca marca 2014 v okviru tarifne kvote za perutninsko meso, odprte z Uredbo (ES) št. 1385/2007
The quantities for which import licence applications have been lodged for the subperiod from 1 April to 30 June 2014 under Regulation (EC) No 1385/2007 shall be multiplied by the allocation coefficients set out in the Annex hereto.
Za zahtevke za uvozna dovoljenja, ki so v skladu z Uredbo (ES) št. 1385/2007 predloženi za podobdobje od 1. aprila do 30. junija 2014, se uporabijo koeficienti dodelitve iz Priloge k tej uredbi.
Regulation (EU) No 282/2014 of the European Parliament and of the Council
Uredba (EU) št. 282/2014 Evropskega parlamenta in Sveta
on the establishment of a third Programme for the Union's action in the field of health (2014-2020) and repealing Decision No 1350/2007/EC
o vzpostavitvi tretjega programa za ukrepe Unije na področju zdravja (2014–2020) in razveljavitvi Sklepa št. 1350/2007/ES
In accordance with Article 168 of the Treaty on the Functioning of the European Union (TFEU), a high level of human health protection is to be ensured in the definition and implementation of all Union policies and activities.
V skladu s členom 168 Pogodbe o delovanju Evropske unije (PDEU) je treba pri opredeljevanju in izvajanju vseh politik in dejavnosti Unije zagotavljati visoko raven varovanja zdravja ljudi.
The Union is to complement and support national health policies, encourage cooperation between Member States and promote the coordination between their programmes, in full respect of the responsibilities of the Member States for the definition of their health policies and the organisation and delivery of health services and medical care.
Unija mora dopolnjevati in podpirati nacionalne zdravstvene politike, spodbujati sodelovanje med državami članicami in usklajevanje njihovih programov ob doslednem spoštovanju odgovornosti držav članic za določanje njihovih zdravstvenih politik ter organizacijo in zagotavljanje zdravstvenih storitev in zdravstvene oskrbe.
Continued effort is required in order to meet the requirements set out in Article 168 TFEU.
Treba si je nenehno prizadevati, da bi izpolnili zahteve iz člena 168 PDEU.
The promotion of good health at Union level is also an integral part of 'Europe 2020: A strategy for smart, sustainable and inclusive growth' ("the Europe 2020 Strategy").
Promocija zdravja na ravni Unije je tudi sestavni del strategije Evropa 2020: strategija za pametno, trajnostno in vključujočo rast (v nadaljnjem besedilu: strategija Evropa 2020).
Keeping people healthy and active longer and empowering them to take an active role in managing their health, will have positive overall effects on health, including a reduction of health inequalities, and a positive impact on quality of life, on productivity and competitiveness, while reducing pressures on national budgets.
Dolgotrajnejše zdravje in aktivnost ljudi ter omogočanje, da prevzamejo aktivno vlogo pri skrbi za lastno zdravje, bodo v celoti pozitivno vplivali na zdravje, tudi na zmanjšanje zdravstvene neenakosti, ter na kakovost njihovega življenja, produktivnost in konkurenčnost, hkrati pa se bo zmanjševal pritisk na nacionalne proračune.
Support for, and recognition of, innovation, which has an impact on health, helps to take up the challenge of sustainability in the health sector in the context of demographic change; and action to reduce inequalities in health is important for the purposes of achieving 'inclusive growth'.
Če bomo podpirali in priznavali inovacije, ki vplivajo na zdravje, se bomo lahko bolje spopadli z izzivom vzdržnosti v zdravstvenem sektorju ob upoštevanju demografskih sprememb, medtem ko so ukrepi za zmanjšanje zdravstvene neenakosti pomembni za namene doseganja „vključujoče rasti“.
It is appropriate in that context to establish the third Programme for the Union's action in the field of health (2014-2020) ('the Programme').
Zato je ustrezno uvesti tretji program za ukrepe Unije na področju zdravja (2014–2020) (v nadaljnjem besedilu: program).
According to the definition of the World Health Organisation (WHO), "Health is a state of complete physical, mental and social well-being and not merely the absence of disease or infirmity.".
V skladu z opredelitvijo Svetovne zdravstvene organizacije (SZO) je „zdravje stanje popolne fizične, duševne in družbene dobrobiti in ne zgolj stanje brez bolezni ali bolehnosti“.
In order to improve the health of the population in the Union and reduce health inequalities, it is essential not to focus only on physical health.
Za izboljšanje zdravja prebivalstva Unije in zmanjšanje zdravstvene neenakosti je bistveno, da se ne osredotočamo zgolj na fizično zdravje.
According to the WHO, mental health problems account for almost 40 % of years lived with disability.
Po podatkih SZO predstavljajo težave z duševnim zdravjem skoraj 40 % let, preživetih v invalidnosti.
Mental health problems are also wide-ranging, long-lasting and a source of discrimination, and contribute significantly to inequality in health.
Težave z duševnim zdravjem imajo poleg tega širok razpon, so dolgotrajne in razlog za diskriminacijo ter znatno prispevajo k zdravstveni neenakosti.
Moreover, the economic crisis affects factors determining mental health, as protective factors are weakened and risk factors increased.
Tudi gospodarska kriza vpliva na dejavnike, ki so odločilni za duševno zdravje, saj se zaščitni dejavniki slabijo, dejavniki tveganja pa krepijo.
The previous programmes of Community action in the field of public health (2003-2008) and in the field of health (2008-2013), adopted respectively by Decisions No 1786/2002/EC [4] and 1350/2007/EC of the European Parliament and of the Council [5] ("the previous health programmes"), have been positively assessed as resulting in a number of important developments and improvements.
Predhodna programa ukrepov Skupnosti na področju javnega zdravja (2003–2008) in na področju zdravja (2008–2013), ki sta bila sprejeta s Sklepom št. 1786/2002/ES Evropskega parlamenta in Sveta [4] oziroma Sklepom št. 1350/2007/ES Evropskega parlamenta in Sveta [5] (v nadaljnjem besedilu: predhodna zdravstvena programa), sta bila pozitivno ocenjena, saj sta prispevala k pomembnemu razvoju in izboljšavam.
The Programme should build on the achievements of the previous health programmes.
Podlaga za program bi morali biti dosežki predhodnih zdravstvenih programov.
It should also take into account the recommendations of the external audits and evaluations carried out, in particular recommendations of the Court of Auditors in its Special Report No 2/2009, according to which, for the period after 2013, the European Parliament, the Council and the Commission should reconsider the scope for Union public health activities and the approach of Union funding in that area.
Upoštevati bi moral tudi priporočila opravljenih zunanjih revizij in ocen, zlasti priporočila Računskega sodišča iz njegovega posebnega poročila št. 2/2009, v skladu s katerimi bi morali Evropski parlament, Svet in Komisija za obdobje po letu 2013 ponovno razmisliti o obsegu dejavnosti Unije na področju javnega zdravja in o pristopu k financiranju s strani Unije na tem področju.
This should be done bearing in mind the budgetary means available and the existence of other cooperation mechanisms as a means of facilitating collaboration and the exchange of information among stakeholders throughout Europe.
Pri tem bi bilo treba upoštevati razpoložljiva proračunska sredstva in obstoj drugih mehanizmov sodelovanja kot sredstev za lajšanje sodelovanja in izmenjave informacij med zainteresiranimi stranmi po vsej Evropi.“
In line with the objectives of the Europe 2020 Strategy, the Programme should focus on a set of well-defined objectives and actions with clear, proven Union added value, and concentrate support on a smaller number of activities in priority areas.
V skladu s cilji strategije Evropa 2020 bi bilo treba v programu poseben poudarek nameniti vrsti dobro opredeljenih ciljev in ukrepov z jasno in dokazano dodano vrednostjo Unije ter podporo osredotočiti na manjše število ukrepov na prednostnih področjih.
The emphasis should be placed, in accordance with the principle of subsidiarity, on areas where there are clear cross-border or internal market issues at stake, or where there are significant advantages and efficiency gains from collaboration at Union level.
V skladu z načelom subsidiarnosti bi moral biti poudarek na področjih, kjer gre za jasna čezmejna vprašanja ali vprašanja notranjega trga ali kjer sodelovanje na ravni Unije prinaša pomembne prednosti in večjo učinkovitost.
The Programme should be a means of promoting actions in areas where there is a Union added value that can be demonstrated on the basis of the following: exchanging good practices between Member States; supporting networks for knowledge sharing or mutual learning; addressing cross-border threats to reduce their risks and mitigate their consequences; addressing certain issues relating to the internal market where the Union has substantial legitimacy to ensure high-quality solutions across Member States; unlocking the potential of innovation in health; actions that could lead to a system for benchmarking to allow informed decision-making at Union level; improving efficiency by avoiding a waste of resources due to duplication and optimising the use of financial resources.
Program bi moral spodbujati ukrepe na področjih, na katerih je podana dodana vrednost Unije, ki jo je mogoče izkazati na podlagi naslednjega: izmenjava dobrih praks med državami članicami; podpiranje mrež za izmenjavo znanja ali vzajemno učenje; obravnavanje čezmejnih nevarnosti za zmanjšanje tveganja in obvladovanje njihovih posledic; reševanje nekaterih vprašanj v zvezi z notranjim trgom, pri katerih ima Unija materialno legitimnost za zagotavljanje visokokakovostnih rešitev v vseh državah članicah; sprostitev inovacijskega potenciala v zdravstvu; ukrepi, ki bi lahko zagotovili sistem za primerljivo spremljanje, da se omogoči informirano odločanje na ravni Unije; izboljšanje učinkovitosti s preprečevanjem izgube sredstev zaradi podvajanja in z optimizacijo uporabe finančnih sredstev.
The implementation of the Programme should be such that the responsibilities of the Member States, for the definition of their health policy and for the organisation and delivery of health services and medical care, are respected.
Med izvajanjem programa bi bilo treba spoštovati odgovornost držav članic, da določijo svojo zdravstveno politiko ter organizirajo in zagotavljajo zdravstvene storitve in zdravstveno oskrbo.
The WHO European Health Report 2009 identifies scope for increasing investment in public health and health systems.
V Poročilu SZO o evropskem zdravju 2009 so opredeljene možnosti za povečanje naložb v javno zdravje in zdravstvene sisteme.
In that regard, Member States are encouraged to identify health improvement as a priority in their national programmes and to benefit from better awareness of the possibilities of Union funding for health.
Države članice naj zato v svojih nacionalnih programih izboljšanje zdravja določijo za prednostno nalogo ter poskrbijo, da jim bo boljše poznavanje možnosti financiranja Unije na področju zdravja prineslo koristi.
Therefore, the Programme should facilitate the uptake of its results into national health policies.
Zato bi bilo treba olajšati prevzemanje rezultatov programa v nacionalne zdravstvene politike.
Innovation in health should be understood as a public health strategy which is not limited to technological advances in terms of products and services.
Inovacije v zdravstvu bi morali obravnavati kot strategijo javnega zdravja, ki ni omejena na tehnološki napredek pri proizvodih in storitvah.
Fostering innovation in the field of public health interventions, prevention strategies, health system management and in the organisation and provision of health services and medical care, including health promotion and disease prevention interventions, has the potential to improve public health outcomes, enhance the quality of care to patients and respond to unmet needs, and also to foster the competitiveness of stakeholders and to improve the cost-efficiency and sustainability of health services and medical care.
S spodbujanjem inovacij na področju varovanja javnega zdravja, strategij preprečevanja, upravljanja zdravstvenih sistemov ter pri organizaciji in zagotavljanju zdravstvenih storitev in zdravstvene oskrbe, tudi pri promociji zdravja in preprečevanju bolezni, lahko izboljšamo rezultate pri javnem zdravju in kakovost oskrbe pacientov ter se odzovemo na neizpolnjene potrebe, hkrati pa spodbudimo konkurenčnost zainteresiranih strani in izboljšamo stroškovno učinkovitost in vzdržnost zdravstvenih storitev in zdravstvene oskrbe.
Therefore, the Programme should facilitate the voluntary uptake of innovation in health, taking into account the common values and principles in European Union Health Systems as set out in the Council Conclusions of 2 June 2006 [6].
Zato bi moral program ob upoštevanju skupnih vrednot in načel zdravstvenih sistemov Evropske unije iz sklepov Sveta z 2. junija 2006 [6] olajšati prostovoljno prevzemanje inovacij v zdravstvu.
The Programme should, in particular in the context of the economic crisis, contribute to addressing health inequalities and the promotion of equity and solidarity through actions under the different objectives and by encouraging and facilitating the exchange of good practices.
Zlasti v razmerah gospodarske krize bi moral program prispevati k odpravi zdravstvene neenakosti ter spodbujanju pravičnosti in solidarnosti z ukrepi v okviru različnih ciljev ter s spodbujanjem in omogočanjem lažje izmenjave dobre prakse.
Pursuant to Articles 8 and 10 TFEU, the Union is to promote equality between men and women and aim to combat discrimination.
V skladu s členoma 8 in 10 PDEU naj bi Unija spodbujala enakost med moškimi in ženskami in si prizadevala za boj proti diskriminaciji.
Accordingly, the Programme should support the mainstreaming of gender equality and anti-discrimination objectives in all its actions.
Tako bi program moral podpirati vključitev načela enakosti spolov in ciljev boja proti diskriminaciji v vseh ukrepih programa.
Patients need to be empowered, inter alia by enhancing health literacy, to manage their health and their healthcare more pro-actively, to prevent poor health and make informed choices.
Pacientom je treba med drugim z izboljšanjem njihove zdravstvene pismenosti omogočiti, da bolj proaktivno skrbijo za svoje zdravje in zdravstveno varstvo, preprečujejo slabo zdravstveno stanje ter se informirano odločajo.
The transparency of healthcare activities and systems and the availability of reliable, independent and user-friendly information to patients should be optimised.
Doseči bi bilo treba najboljšo možno preglednost dejavnosti in sistemov zdravstvenega varstva ter razpoložljivosti zanesljivih, neodvisnih in uporabniku prijaznih informacij za paciente.
Healthcare practices should be informed by feedback from, and communication with, patients.
Zdravstvene ambulante bi se morale seznanjati s povratnimi informacijami pacientov in informacije pridobivati s komuniciranjem z njimi.
Support for Member States, patient organisations and stakeholders is essential and should be coordinated at Union level in order to help patients in an effective manner, in particular those affected by rare diseases, to benefit from cross-border healthcare.
Podpora državam članicam, organizacijam pacientov in zainteresiranim stranem je ključna in bi morala biti usklajena na ravni Unije, da se pacientom, zlasti tistim z redkimi boleznimi, učinkovito pomaga, da izkoristijo čezmejno zdravstveno varstvo.
Reducing the burden of resistant infections and healthcare associated infections and securing the availability of effective antimicrobials is essential for the efficiency of health systems and for the safety of patients.
Za učinkovitost zdravstvenih sistemov in varnost pacientov je treba zmanjšati breme odpornih okužb in okužb, povezanih z zdravstveno oskrbo, ter zagotoviti razpoložljivost učinkovitih protimikrobnih sredstev.
The Programme should support sustained efforts to improve methods of analysis to detect and prevent antimicrobial resistance and improve networking among all healthcare actors, including the veterinary sector, in relation to dealing with antimicrobial resistance.
S programom bi bilo treba podpreti nenehna prizadevanja za izboljšanje analitičnih metod za odkrivanje in preprečevanje protimikrobne odpornosti ter izboljšati povezovanje vseh akterjev v zdravstvenem varstvu, tudi veterinarskega sektorja, pri obravnavanju protimikrobne odpornosti.
In the context of an ageing society, well-directed investments to promote health and prevent diseases can increase the number of 'healthy life years' and thus enable the elderly to enjoy a healthy and active life as they get older.
V starajoči se družbi lahko z dobro usmerjenimi naložbami v promocijo zdravja in preprečevanje bolezni povečamo število „let zdravega življenja“ ter tako starejšim omogočimo, da tudi v starosti živijo zdravo in aktivno.